There are four active Centers of Excellence (CFE) at Oslo University Hospital, hosted by the University of Oslo. The centers are multi-year initiatives under the auspices of the Research Council of Norway. CanCell and Hybrid Technology Hub are funded under CFE IV (2017–2027). The Center for Embryology and the Center for Precision Immunotherapy are funded under CFE V (2023–33).

• CanCell – Centre for Cancer Cell Reprogramming
• CRESCO – Senter for embryologi
• HTH – Senter for biohybridteknologi – Centre for Organ on a Chip-Technology
• PRIMA – Senter for presisjons-immunterapi

FKB are multi-year initiatives under the auspices of the Research Council of Norway. There is one active FKB at Oslo University Hospital. MATRIX is funded under the FKB scheme for the period 2022-2030.

Nasjonalt Forskningssenter for Klinisk Kreftbehandling - Matrix

K.G. Jebsen Centres for Medical Research home page - overview of current and former centres

Led by researchers affiliated to OUH:

• K.G. Jebsen Centre for Brain Fluid Research - led by Per Kristian Eide. Centre period: 2024 – 2029.
• K. G. Jebsen Centre for Neurodevelopmental Disorders - led by Terje Nærland. Centre period: 2020 – 2026